Entity Details
Primary name |
CLD16_HUMAN |
Entity type |
UniProt |
Source |
Source Link |
Details
Accession | Q9Y5I7 |
EntryName | CLD16_HUMAN |
FullName | Claudin-16 |
TaxID | 9606 |
Evidence | evidence at protein level |
Length | 305 |
SequenceStatus | complete |
DateCreated | 2000-05-30 |
DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
Subcellular Location |
Cell junction |
Cell membrane |
Domains
Show/Hide Table
Domain | Name | Category | Type |
IPR003927 | Claudin-16 | Family | Family |
IPR004031 | PMP-22/EMP/MP20/Claudin superfamily | Family | Family |
IPR006187 | Claudin | Family | Family |
IPR017974 | Claudin, conserved site | Site | Conserved site |
Diseases
Show/Hide Table
Disease ID | Source | Name | Description |
248250 | OMIM | Hypomagnesemia 3 (HOMG3) | A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis. Recurrent urinary tract infections and kidney stones are often observed. In spite of hypercalciuria, patients do not show hypocalcemia. The disease is caused by variants affecting the gene represented in this entry. |
Drugs
Show/Hide Table
Drug | Name | Source | Type |
DB14513 | Magnesium | Swissprot | small molecule |
Interactions
3 interactions